(Q47373065)

15 January 2018

title

Hypofractionated conformal radiotherapy in carcinoma of the prostate: five-year outcome analysis (English)

1 reference

15 January 2018

adaptive radiation therapy

main subject

0 references

Richard A Cowan

2

0 references

author name string

Jacqueline E Livsey

1

1 reference

15 January 2018

James P Wylie

3

1 reference

15 January 2018

Ric Swindell

4

1 reference

15 January 2018

Graham Read

5

1 reference

15 January 2018

Vincent S Khoo

6

1 reference

15 January 2018

John P Logue

7

1 reference

15 January 2018

language of work or name

English

0 references

publication date

1 December 2003

1 reference

15 January 2018

International Journal of Radiation Oncology Biology Physics

published in

1 reference

15 January 2018

volume

57

1 reference

15 January 2018

issue

5

1 reference

15 January 2018

page(s)

1254-1259

1 reference

15 January 2018

Fractionation and protraction for radiotherapy of prostate carcinoma

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900752-1

7 January 2021

Is alpha/beta for prostate tumors really low?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900752-1

7 January 2021

Cell production rates in human tissues and tumours and their significance. Part II: clinical data

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900752-1

7 January 2021

Hypofractionation for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900752-1

7 January 2021

Short-course intensity-modulated radiotherapy (70 GY at 2.5 GY per fraction) for localized prostate cancer: preliminary results on late toxicity and quality of life.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900752-1

7 January 2021

Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900752-1

7 January 2021

Retrospective study of radiotherapy in early carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900752-1

7 January 2021

Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900752-1

7 January 2021

Importance of high radiation doses (72 Gy or greater) in the treatment of stage T1-T3 adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900752-1

7 January 2021

Dose escalation with 3D conformal treatment: five year outcomes, treatment optimization, and future directions.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900752-1

7 January 2021

Preliminary results of a randomized radiotherapy dose-escalation study comparing 70 Gy with 78 Gy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900752-1

7 January 2021

Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900752-1

7 January 2021

Defining the optimal radiation dose with three-dimensional conformal radiation therapy for patients with nonmetastatic prostate carcinoma by using recursive partitioning techniques.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900752-1

7 January 2021

External beam radiotherapy dose response characteristics of 1127 men with prostate cancer treated in the PSA era

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900752-1

7 January 2021

Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900752-1

7 January 2021

Complications from radiotherapy dose escalation in prostate cancer: preliminary results of a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900752-1

7 January 2021

Interim report of toxicity from 3D conformal radiation therapy (3D-CRT) for prostate cancer on 3DOG/RTOG 9406, level III (79.2 Gy).

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900752-1

7 January 2021

The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900752-1

7 January 2021

The MOS 36-ltem Short-Form Health Survey (SF-36)

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900752-1

7 January 2021

Short Report: A Morbidity Scoring System for Clinical Oncology Practice: Questionnaires produced from the LENT SOMA scoring system

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900752-1

7 January 2021

Scoring of treatment-related late effects in prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900752-1

7 January 2021

10.1016/S0360-3016(03)00752-1

Identifiers

DOI

1 reference

15 January 2018

1 reference

15 January 2018